Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting M2-like tumor-associated macrophages by using melittin-based proapoptotic peptide

Targeting M2-like tumor-associated macrophages by using melittin-based proapoptotic peptide

US Patent 11484601 · Granted Nov 1, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition including melittin for removing M2-type tumor-associated macrophage2023
Apparatus, server, system and method for energy measuring2018
Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for t2018
Pharmaceutical composition comprising bee venom-phospholipase A2 (bv-PLA2) for t2018
Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for t2016
Liposome composition for treating acne containing conjugate of lysophosphatidylc2016
Cyclic pentadepsipeptide derivative and fusarium strain producing the same2016
Cyclic pentadepsipeptides and microorganism of Fusarium strain producing the sam2015
Method of preparing secondary amine compound using microflow reactor2014